The Power of iHope

26 February 2019

Families of children with an undiagnosed disease often face years-long diagnostic odysseys. Hear from health care providers and families who have participated in iHope, a philanthropic program from Illumina that helps patients access clinical whole-genome sequencing. Through its growing global network, iHope is helping providers and patients find the answers they seek. Learn more about finding answers for children with rare and undiagnosed genetic diseases at Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on